CD8A and neoplasm: A number of reports support a protecting role of specific FMT against development and progression of melanoma (Le Bastard et al., 2018; Wang et al., 2019) possibly enhancing anti-tumor immune responses mediated by increased dendritic cells activity, and improved priming of CD8 T cells in and around the tumor microenvironment.